These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 2881923

  • 1. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV, Brown WA, Laughren TP.
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [Abstract] [Full Text] [Related]

  • 2. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
    Brown WA, Silver MA.
    J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
    [Abstract] [Full Text] [Related]

  • 3. Reducing the dose of depot neuroleptics in stable schizophrenia.
    Dale R, Longdon M, Seeman MV.
    J Psychiatry Neurosci; 1994 Jul; 19(4):278-81. PubMed ID: 7918349
    [Abstract] [Full Text] [Related]

  • 4. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
    Csernansky JG, Kaplan J, Holman CA, Hollister LE.
    Psychopharmacology (Berl); 1983 Jul; 81(2):115-8. PubMed ID: 6138793
    [Abstract] [Full Text] [Related]

  • 5. Trial of maintenance neuroleptic dose reduction in schizophrenic outpatients: two-year outcome.
    Heresco-Levy U, Greenberg D, Lerer B, Dasberg H, Brown WA.
    J Clin Psychiatry; 1993 Feb; 54(2):59-62. PubMed ID: 8095259
    [Abstract] [Full Text] [Related]

  • 6. Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics.
    Young AS, Faraone SV, Brown WA.
    J Clin Psychopharmacol; 1989 Oct; 9(5):361-3. PubMed ID: 2571620
    [Abstract] [Full Text] [Related]

  • 7. Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy.
    Heresco-Levy U, Greenberg D, Lerer B, Javitt DC, Brown WA.
    Isr J Psychiatry Relat Sci; 1997 Oct; 34(4):281-9. PubMed ID: 9409085
    [Abstract] [Full Text] [Related]

  • 8. [Discontinuation of antipsychotic drugs in chronic schizophrenic patients. II. Psychological and psychopathological test differences between patients with and without relapse].
    Woggon B, Bickel P, Schnyder B.
    Int Pharmacopsychiatry; 1979 Oct; 14(5):278-93. PubMed ID: 43849
    [Abstract] [Full Text] [Related]

  • 9. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
    Albus M, Naber D, Ackenheil M, Bürke H, Müller-Spahn F, Münch U, Reinertshofer T, Schmidt-Vanderheyden W, Weber G, Wissmann J.
    Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
    [Abstract] [Full Text] [Related]

  • 10. Relations between psychotic symptoms and serum prolactin levels.
    Roncoroni D.
    Pharmacopsychiatry; 1989 Mar; 22(2):71-5. PubMed ID: 2566181
    [Abstract] [Full Text] [Related]

  • 11. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K, Awata S, Takano T, Ebina Y, Iwasaki H, Matsuoka H.
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [Abstract] [Full Text] [Related]

  • 12. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
    Nakajima M, Terao T, Iwata N, Nakamura J.
    Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
    [Abstract] [Full Text] [Related]

  • 13. Early phase II clinical trial of remoxipride in treatment of schizophrenia with measurements of prolactin and neuroleptic activity.
    Chouinard G.
    J Clin Psychopharmacol; 1987 Jun; 7(3):159-64. PubMed ID: 2885345
    [Abstract] [Full Text] [Related]

  • 14. A study of the pharmacologic treatment of medication-compliant schizophrenics who relapse.
    Steingard S, Allen M, Schooler NR.
    J Clin Psychiatry; 1994 Nov; 55(11):470-2. PubMed ID: 7989278
    [Abstract] [Full Text] [Related]

  • 15. Antipsychotic medication: clinical guidelines for maintenance therapy.
    Johnson DA.
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
    [Abstract] [Full Text] [Related]

  • 16. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics.
    Naber D, Ackenheil M, Laakman G, Fischer H, von Werder K.
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):325-30. PubMed ID: 6111094
    [Abstract] [Full Text] [Related]

  • 17. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S, Lieberman J, Pollack S, Kane JM, Safferman A, Munne R, Umbricht D, Woerner M, Masiar S, Kronig M.
    Biol Psychiatry; 1996 Feb 15; 39(4):249-54. PubMed ID: 8645771
    [Abstract] [Full Text] [Related]

  • 18. Inpatient violence and the schizophrenic patient: an inverse correlation between danger-related events and neuroleptic levels.
    Yesavage JA.
    Biol Psychiatry; 1982 Nov 15; 17(11):1331-7. PubMed ID: 7150681
    [Abstract] [Full Text] [Related]

  • 19. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP, Smith D, Katz I.
    J Clin Psychiatry; 1984 Mar 15; 45(3):117-9. PubMed ID: 6142035
    [Abstract] [Full Text] [Related]

  • 20. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
    Naber D, Ackenheil M, Laakmann G.
    Adv Biochem Psychopharmacol; 1980 Mar 15; 24():419-23. PubMed ID: 6105792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.